INHBA-AS1: A Potential Drug Target for Cancer and Inflammatory Diseases

Target Name: INHBA-AS1

NCBI ID: G285954

INHBA-AS1

Other Name(s): INHBA antisense RNA 1 | INHBA antisense RNA 1, transcript variant 1

INHBA-AS1: A Potential Drug Target for Cancer and Inflammatory Diseases

The INHBA-AS1 (INHBA antisense RNA 1) molecule is a protein that is expressed in human tissues and has been shown to play a role in various biological processes. The INHBA gene is located on chromosome 6 and encodes for a protein that is involved in the regulation of cell adhesion, migration and invasion. INHBA-AS1 has also been shown to be involved in the regulation of inflammation and immune responses.

The Importance of INHBA-AS1

INHBA-AS1 has been shown to play a critical role in the regulation of cell-cell adhesion and tissue organization. This protein has been shown to interact with various cellular signaling pathways, including the TGF-β pathway. TGF-β is a well-known signaling pathway that is involved in the regulation of cell growth, differentiation and inflammation.

INHBA-AS1 has been shown to play a role in the regulation of TGF-β signaling by negativeulating the activity of the transcription factor, SMAD. SMAD is a protein that is involved in the regulation of gene expression and has been shown to play a role in the regulation of cellular processes such as cell adhesion, migration and invasion.

Additionally, INHBA-AS1 has also been shown to play a role in the regulation of the NF-kappa-B signaling pathway. NF-kappa-B is a signaling pathway that is involved in the regulation of inflammation and immune responses.

Drug Targeting INHBA-AS1

The INHBA-AS1 protein has been identified as a potential drug target in the field of cancer and inflammatory diseases. Studies have shown that INHBA-AS1 has been shown to play a role in the regulation of cancer cell growth, migration and invasion.

In addition, INHBA-AS1 has also been shown to play a role in the regulation of inflammatory responses. This protein has been shown to interact with various cellular signaling pathways, including the NF-kappa-B signaling pathway.

The Potential Applications of INHBA-AS1

The INHBA-AS1 protein has the potential to be used as a drug target in the treatment of various diseases, including cancer and inflammatory diseases. Studies have shown that INHBA-AS1 has been shown to play a role in the regulation of cancer cell growth, migration and invasion.

In addition, INHBA-AS1 has also been shown to play a role in the regulation of inflammatory responses. This protein has been shown to interact with various cellular signaling pathways, including the NF-kappa-B signaling pathway.

Conclusion

INHBA-AS1 is a protein that has been shown to play a role in various biological processes, including the regulation of cell adhesion, migration and invasion, and the regulation of inflammation. The INHBA-AS1 gene is located on chromosome 6 and encodes for a protein that is involved in the regulation of cell adhesion, migration and invasion.

INHBA-AS1 has the potential to be used as a drug target in the treatment of various diseases, including cancer and inflammatory diseases due to its involvement in the regulation of cancer cell growth, migration and invasion and inflammatory responses. Further studies are needed to fully understand the role of INHBA-AS1 in these processes and to develop effective treatments.

Protein Name: INHBA Antisense RNA 1

The "INHBA-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about INHBA-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets